BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32615981)

  • 1. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia.
    van Loon W; Gomez MP; Jobe D; Franken KLMC; Ottenhoff THM; Coninx M; Kestens L; Sutherland JS; Kampmann B; Tientcheu LD
    BMC Infect Dis; 2020 Jul; 20(1):469. PubMed ID: 32615981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
    Krutikov M; Faust L; Nikolayevskyy V; Hamada Y; Gupta RK; Cirillo D; Mateelli A; Korobitsyn A; Denkinger CM; Rangaka MX
    Lancet Infect Dis; 2022 Feb; 22(2):250-264. PubMed ID: 34606768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close contact interferon-gamma response to the new PstS1
    de Araujo LS; de Bárbara Moreira da Silva Lins N; Leung JA; Mello FC; Saad MH
    BMC Res Notes; 2017 Jan; 10(1):59. PubMed ID: 28114976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis infection screening in children with close contact: a hospital-based study.
    Sun L; Qi X; Guo Y; Qi H; Li J; Wu X; Yin Q; Guo Y; Xu B; Wang Y; Jin Q; Gao L; Shen A
    BMC Infect Dis; 2021 Aug; 21(1):815. PubMed ID: 34388985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.
    Schepers K; Mouchet F; Dirix V; De Schutter I; Jotzo K; Verscheure V; Geurts P; Singh M; Van Vooren JP; Mascart F
    Clin Vaccine Immunol; 2014 Feb; 21(2):111-8. PubMed ID: 24152386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test.
    Shakak AO; Khalil EA; Musa AM; Salih KA; Bashir AE; Ahmed AH; Idris FE; Elhassan AM;
    BMC Public Health; 2013 Dec; 13():1128. PubMed ID: 24313987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.
    Kampmann B; Seddon JA; Paton J; Nademi Z; Keane D; Williams B; Williams A; Liebeschutz S; Riddell A; Bernatoniene J; Patel S; Martinez N; McMaster P; Basu-Roy R; Welch SB
    Am J Respir Crit Care Med; 2018 Apr; 197(8):1058-1064. PubMed ID: 29190430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.